http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016204132-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1627f2ed7f5bddbaaf7c1a98f79d41d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bca66bbab0720d487807c526baf0631 |
| publicationDate | 2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2016204132-B2 |
| titleOfInvention | Enterically coated cysteamine, cystamine and derivatives thereof |
| abstract | Abstract Title: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects. |
| priorityDate | 2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 162.